According to Inotiv's latest financial reports the company's current earnings (TTM) are -$40.66 M. In 2022 the company made an earning of -$0.36 B a decrease over its 2021 earnings that were of -$89.75 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$40.66 M | -88.68% |
2022 | -$0.36 B | 300.21% |
2021 | -$89.75 M | 2433.68% |
2020 | -$3.55 M | 74.4% |
2019 | -$2.04 M | 583.84% |
2018 | -$0.3 M | -135.02% |
2017 | $0.84 M | -131.18% |
2016 | -$2.72 M | -738.5% |
2015 | $0.42 M | -295.41% |
2014 | -$0.22 M | 68.99% |
2013 | -$0.13 M | -96.87% |
2012 | -$4.13 M | 226.5% |
2011 | -$1.27 M | 3.02% |
2010 | -$1.23 M | -76.34% |
2009 | -$5.19 M | 142.29% |
2008 | -$2.14 M | -277.15% |
2007 | $1.2 M | -143.71% |
2006 | -$2.77 M | -436.02% |
2005 | $0.82 M | 168.76% |
2004 | $0.3 M | -336.43% |
2003 | -$0.13 M | -108.29% |
2002 | $1.56 M | -50.63% |
2001 | $3.16 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -$2.17 M | -94.68% | Bahamas |
NRC Health
NRC | $40.82 M | -200.41% | ๐บ๐ธ USA |